nutrition
Mansour Karajibani; Fatemeh Esmaili Ranjbar; Hadi Eslahi; Farzaneh Montazerifar; ali reza dashipour
Volume 29, Issue 3 , September and October 2022, , Pages 393-405
Abstract
Introduction: Preeclampsia and eclampsia are pregnancy specific syndromes. Vitamin D is one of the pathological factors of this syndrome. The aim of this study was to compare the serum levels of vitamin D in pregnant women with preeclampsia or eclampsia with healthy pregnant women.
Materials and Methods: ...
Read More
Introduction: Preeclampsia and eclampsia are pregnancy specific syndromes. Vitamin D is one of the pathological factors of this syndrome. The aim of this study was to compare the serum levels of vitamin D in pregnant women with preeclampsia or eclampsia with healthy pregnant women.
Materials and Methods: In a cross-sectional, descriptive and analytical study, 50 pregnant women with preeclampsia or eclampsia and 50 healthy individuals were selected based on inclusion and exclusion criteria, and after taking blood sampling, serum vitamin D levels were measured using a commercial kit and ELISA. Statistical analysis was done by SPSS: 20. P <0.05 was considered as significant difference.
Results: The mean serum vitamin D in pregnant women with preeclampsia or eclampsia was lower than the healthy group (P = 0.002). Also, 38% and 2% of pregnant women with preeclampsia or eclampsia and healthy had severe vitamin D deficiency. Vitamin D deficiency was more common in pregnant women over 30 years of age and BMI over 25, education less than a diploma, a housewife, and a gestational age of less than 34 weeks.
Conclusion: The results indicate that most pregnant women with preeclampsia and eclampsia syndrome are deficient in vitamin D, which affect in the development of preeclampsia or eclampsia. Therefore, timely screening and treatment of vitamin D deficiency can probably prevent preeclampsia or eclampsia and promote the quality of pregnancy.
Gyneocology
Farzaneh Montazerifar; Marzieh Ghasemi; Rasul Taghvaee far; Mahdieh Keykhahnejad; Mansour Karajibani; Ebrahim Alijani
Volume 28, Issue 2 , May and June 2021, , Pages 294-301
Abstract
Introduction: Polycystic ovary syndrome (PCOS) is one of the most common hormonal disorders in women of infertility. Women with PCOS are at high risk for early cardiovascular disease. The aim of this study was to evaluate the oxidative stress, inflammatory factors and other cardiovascular risk factors ...
Read More
Introduction: Polycystic ovary syndrome (PCOS) is one of the most common hormonal disorders in women of infertility. Women with PCOS are at high risk for early cardiovascular disease. The aim of this study was to evaluate the oxidative stress, inflammatory factors and other cardiovascular risk factors in patients with PCOS. Materials and methods: In this case-control study, 50 women with PCOS and 50 healthy women referred to Zahedan Infertility Clinic who were matched for age and BMI were selected by convenient sampling method. Anthropometric parameters, biochemical tests, C3 and C4 complements, TAC and MDA levels were measured in all subjects. Data were analyzed using independent t-test and analysis of variance at the significant level P Results: Results showed that mean waist circumference (P = 0.048), systolic blood pressure (P <0.01) and diastolic (P = 0.048), serum LDLC levels (P = 0.05) and MDA (P <0.0001) were significantly higher in women with PCOS and serum HDL-C levels (P = 0.03) and TAC (P = 0.05) were significantly lower than control group. Mean serum levels of C3 and C4 were higher in the PCOS group than in the control group, but this difference was only significant for C3 (P = 0.03) . Conclusion: The findings showed that levels of dyslipidemia, oxidative stress and inflammatory factors were higher in PCOS women with abdominal obesity. Thus, screening of these factors and weight management, especially in obese women with polycystic ovary syndrome, is recommended in treatment strategy.